
06 Feb 2023
VEON announces ratio change under its American Depositary Receipt ( ADR ) program Amsterdam, Netherlands, 6 February 2023 07:00 CET: VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON) ( VEON or the Company ), a global digital operator that provides converged connectivity and online services, announced today that its Board of Directors (the Board ) has approved a change of ratio in the Company's ADR program, comprising a change in the ratio of American Depositary Shares (the ADSs ) to VEON common shares (the Shares ) from one (1) ADS representing one (1) Share, to one (1) ADS representing twenty-five (25) Shares (the Ratio Change ). The effective date of the Ratio Change (the Effective Date ) is expected to be 6 March 2023.
Pursuant to the Ratio Change, as of the Effective Date, record holders who directly hold ADRs will be required to exchange their existing ADRs for new ADRs on the basis of one (1) new ADR for every twenty-five (25) existing ADRs surrendered. The Depositary will contact ADR holders and arrange for the exchange of their existing ADRs for new ADRs. ADS beneficial holders who hold through an ADR holder intermediary need not take any action in connection with the Ratio Change.
For ADS holders, the Ratio Change will have the same effect as a one for twenty five reverse ADS split. No new Shares will be issued in connection with the Ratio Change and the ADSs will continue to be traded on The Nasdaq Capital Market under the symbol VEON.
As a result of the Ratio Change, the trading price of the Company's ADSs is expected to automatically increase proportionally, but the Company can give no assurance that the ADS trading price following the Ratio Change will be at least equal to the ADS trading price before the Ratio Change multiplied by the new 25:1 ratio. As VEON announced previously on 5 October 2022, the Listing Qualifications Department of The Nasdaq Market granted VEON an additional grace period through 3 April 2023 to regain compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rule 5550(a)(2) (the Minimum Bid Price ). While the Ratio Change is intended to bring the bid price of the Company's ADSs into compliance with the Minimum Bid Price, the Company can give no assurance that the Ratio Change will be effective in achieving this goal.
VEON Group CEO Kaan Terzioglu commented: We believe the Ratio Change is in the best interest of all our stakeholders, as it will allow us to ensure VEON's continued Nasdaq listing and provide a pathway toward increasing VEON's visibility on Nasdaq.
About VEON
VEON is a global digital operator that currently provides converged connectivity and online services to over 200 million customers in seven dynamic markets. We are transforming people's lives, empowering individuals, creating opportunities for greater digital inclusion and driving economic growth across countries that are home to more than 8% of the world's population. Headquartered in Amsterdam, VEON is listed on NASDAQ and Euronext.
For more information visit: www.veon.com.
Important Notice
This release is for informational purposes only and shall not constitute a prospectus or an offer to sell or the solicitation of an offer to buy securities in the United States or any other jurisdiction, nor shall there be any offer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under applicable securities laws.
This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129.
This communication or information contained herein is not an offer, or an invitation to make offers, to sell, exchange or otherwise transfer securities in the Russian Federation to or for the benefit of any Russian person or entity and does not constitute an advertisement or offering of securities in the Russian Federation within the meaning of Russian securities laws.
Elements of this press release contain or may contain inside information as defined under the Market Abuse Regulation (EU) No. 596/2014.
Disclaimer
This release contains forward-looking statements, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, expectations regarding the Ratio Change and the benefits of the Ratio Change, including compliance with the Minimum Bid Price. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws and except as set forth above, any forward-looking statement to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
Contact information
VEON
Nik Kershaw
Group Director Investor Relations
ir@veon.com
This website stores cookies on your computer. These cookies are used to improve vour website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy
We wont track your information when you visit our site. But in order to comply with your preferences, well have to use just one tiny cookie so that youre not asked to make this choice again.
AcceptDecline
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
06/08/2026
The BBC has announced casting for the forthcoming six-part series Hercule from Mammoth Screen and Agatha Christie Limited.
Joining Bluemel are Henry Ashton (A ...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Proven offering builds on more than 20,000 live sporting events with greater automation, flexibility, and operational control
LTN , the industry leader in tran...
06/08/2026
Hornets Tech, a specialist in broadcast connectivity and IP video, is bringing a new range of encoders, decoders and an IPTV platform to IBC2026.
Broadcast in...
06/08/2026
Introducing Adobe for ChatGPT: Create, edit and get work done - all in ChatGPT
Deepti Pradeep August 6, 2026
0 Comments
The Adobe plugin in ChatGPT br...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At IBC2026, MediaKind will make its first major appearance as a unified global powerhouse in video, showcasing one of the world's most comprehensive video i...
06/08/2026
Big Blue Marble (#5.A63) will demonstrate how its integrated technology and operational expertise help media companies scale premium services with less complexi...
06/08/2026
LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...
06/08/2026
LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...
06/08/2026
LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...
06/08/2026
LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....
06/08/2026
LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...
06/08/2026
Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...
06/08/2026
LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...
06/08/2026
LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...
06/08/2026
LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...
06/08/2026
Scripps Research's Skaggs Graduate School of Chemical and Biological Science...
06/08/2026
LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...
06/08/2026
LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...
06/08/2026
LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...
06/08/2026
LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...
06/08/2026
LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...
06/08/2026
LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...
06/08/2026
LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...
06/08/2026
LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...
06/08/2026
LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...
06/08/2026
LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Crowned with the 2006 Nobel Priz...
06/08/2026
LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...
06/08/2026
LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...
06/08/2026
LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...
06/08/2026
LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...
06/08/2026
LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...
06/08/2026
LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At this year's SET EXPO, PlayBox Neo will present recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solutions. By show...
06/08/2026
Live demo at IBC2026 VisualOn Booth, Hall 5, Stand A55
Amsterdam, Netherlands Modern Streaming Solutions Private Limited, a rising force in India's dig...
06/08/2026
Screen Australia and YouTube Australia fund five new teams through eleventh Skip...
06/08/2026
How Karukera Studio Built a Media Production Hub with SNS EVO
Melanie Ciotti August 5, 2026
0 Comments
Hero images displays Karukera Studio in Sainte-...
06/08/2026
NHK drama series Rosanjin no Kamado shot on PYXIS 6K
Brie Clayton August 5, 2026
0 Comments
Blackmagic PYXIS 6K and DaVinci Resolve Studio capture the...
06/08/2026
Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D
Jamie Cardoso August 5, 2026
0 Comments
If you do any kind of Architectural Vi...
06/08/2026
Fox Corporation Reports Fourth Quarter and Full Year Fiscal 2026 Financial Resul...